0000899243-16-035219.txt : 20161209 0000899243-16-035219.hdr.sgml : 20161209 20161209160536 ACCESSION NUMBER: 0000899243-16-035219 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161207 FILED AS OF DATE: 20161209 DATE AS OF CHANGE: 20161209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wahlstrom Mats CENTRAL INDEX KEY: 0001459154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 162044090 MAIL ADDRESS: STREET 1: 500 GOLDEN RIDGE ROAD, SUITE 100 CITY: GOLDEN STATE: CO ZIP: 80401 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-12-07 0 0001512762 Coherus BioSciences, Inc. CHRS 0001459154 Wahlstrom Mats C/O COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 1 0 0 0 Common Stock, $0.0001 par value 2016-12-07 4 S 0 7393 27.503 D 46190 I See Footnote Common Stock, $0.0001 par value 2016-12-08 4 S 0 46190 27.5243 D 0 I See Footnote Common Stock, $0.0001 par value 578528 I See Footnote The transaction was executed in multiple trades in prices ranging from $27.50 to $27.55, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein. The transaction was executed in multiple trades in prices ranging from $27.50 to $27.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The shares are held by KMG Capital Partners, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein. /s/ Jean Frederic Viret, as Attorney in Fact for Mats Wahlstrom 2016-12-09